 |
|
 |
|
|
|
Emergent BioSolutions Inc.
2273 Research Boulevard, Suite 400
Rockville, MD 20850
301-795-1800
Visit Website
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the body's immune system to prevent or treat disease. Emergent's marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax disease. Emergent's product pipeline targets infectious diseases and includes programs focused on anthrax, tuberculosis, typhoid, flu and chlamydia.
Company Management
- Fuad El-Hibri, CEO
- R. Don Elsey, CFO
- R. Don Elsey, Investor Relations Contact
Westwicke Contacts
Request a Meeting
|
|
|
